晚期发病的糖原储存疾病类型IIIa病例中的多种电生理学脱髓化特征
Xiajun Zhou1, Xingxing Zhong2, Mingshi Gao3
1Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200127, China.
Open medicine (Warsaw, Poland)
|May 5, 2025
概括
糖原储存疾病类型IIIa (GSD IIIa) 可以表现为脱髓化,而不仅仅是轴心病. 这种罕见的成人发作的肌肉病变病例显示了显著的神经损伤,这表明糖原会影响髓.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 糖原储存疾病类型IIIa (GSD IIIa) 是一种罕见的代谢障碍.
- 它通常呈现为成人发作的肌肉病变,通常与轴突病变有关.
研究的目的:
- 报告一个独特的GSD IIIa病例,具有突出的脱髓化特征.
- 调查糖原积累对髓的潜在影响.
- 扩大对GSD IIIa疾病谱的理解.
主要方法:
- 对GSD IIIa.的遗传确认
- 病理检查受影响的组织.
- 详细的电生理学研究 (神经导电研究和电肌学).
主要成果:
- 这位患者出现了成人发作的肌肉病变.
- 电生理学发现表明显著的脱髓化 (延长远部运动延迟,时间分散,延长F波,导电阻塞).
- 这些脱髓化特征是突出的,不能归因于其他原因.
结论:
- GSD IIIa可以表现出显著的非髓化特征,挑战与轴心病的典型关联.
- 糖原积累可能直接影响周围神经髓.
- 这一病例扩大了GSD IIIa. 的已知临床和病理谱.
相关概念视频
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Amyloid Fibrils
9.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.0K
Myasthenia Gravis: Diagnostic Tests
531
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
531


